Gregory Flesher
Directeur Général chez RENEO PHARMACEUTICALS, INC.
Fortune : 35 032 $ au 30/06/2024
Profil
Mr. Gregory J.
Flesher is a President, Chief Executive Officer & Director at Reneo Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at Reneo Pharma Ltd.
He is on the Board of Directors at Reneo Pharmaceuticals, Inc. and Reneo Pharma Ltd.
Mr. Flesher was previously employed as a Chief Executive Officer & Director by Novus Therapeutics, Inc., a Chief Executive Officer & Director by Otic Pharma Ltd., a Chief Business Officer & SVP-Corporate Development by Avanir Pharmaceuticals, Inc., and a Director-Hepatology Sales & Pulmonary Marketing by InterMune, Inc. He also served on the board at Adynxx, Inc. He received his undergraduate degree from Purdue University and an undergraduate degree from The Indiana University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 23 200 ( 0,07% ) | 35 032 $ | 30/06/2024 |
Postes actifs de Gregory Flesher
| Sociétés | Poste | Début |
|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Directeur Général | 09/12/2020 |
| Reneo Pharma Ltd. | Directeur Général | - |
Anciens postes connus de Gregory Flesher
| Sociétés | Poste | Fin |
|---|---|---|
| ADYNXX, INC. | Directeur/Membre du Conseil | 01/06/2021 |
| ELEDON PHARMACEUTICALS, INC. | Directeur Général | 04/09/2020 |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Directeur Général | 01/05/2017 |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2015 |
| INTERMUNE INC | Sales & Marketing | 01/01/2006 |
Formation de Gregory Flesher
| Purdue University | Undergraduate Degree |
| The Indiana University School of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| ADYNXX, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
| Reneo Pharma Ltd. |
